Compare Stocks: BHC, BLCO, ALC, and BLCO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$70.17 +1.8%	$67.26	$61.83 ▼ $90.41	$34.71B	0.88	1.90 million shs	1.90 million shs
BHC Bausch Health Cos	$7.01 +1.7%	$4.99	$4.33 ▼ $8.69	$2.62B	0.42	2.42 million shs	9.46 million shs
BLCO Bausch + Lomb	$16.79 -0.7%	$15.93	$13.53 ▼ $18.92	$5.99B	0.56	434,726 shs	406,272 shs
BLCO Bausch + Lomb	$16.79 -0.7%	$15.93	$13.53 ▼ $18.92	$5.99B	0.56	434,726 shs	406,272 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	0.00%	+1.53%	-1.06%	-7.09%	-21.55%
BHC Bausch Health Cos	0.00%	+55.84%	+40.02%	+22.01%	+20.77%
BLCO Bausch + Lomb	0.00%	+4.02%	-1.97%	+3.57%	+24.95%
BLCO Bausch + Lomb	0.00%	+4.02%	-1.97%	+3.57%	+24.95%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$70.17 +1.8%	$67.26	$61.83 ▼ $90.41	$34.71B	0.88	1.90 million shs	1.90 million shs
BHC Bausch Health Cos	$7.01 +1.7%	$4.99	$4.33 ▼ $8.69	$2.62B	0.42	2.42 million shs	9.46 million shs
BLCO Bausch + Lomb	$16.79 -0.7%	$15.93	$13.53 ▼ $18.92	$5.99B	0.56	434,726 shs	406,272 shs
BLCO Bausch + Lomb	$16.79 -0.7%	$15.93	$13.53 ▼ $18.92	$5.99B	0.56	434,726 shs	406,272 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	0.00%	+1.53%	-1.06%	-7.09%	-21.55%
BHC Bausch Health Cos	0.00%	+55.84%	+40.02%	+22.01%	+20.77%
BLCO Bausch + Lomb	0.00%	+4.02%	-1.97%	+3.57%	+24.95%
BLCO Bausch + Lomb	0.00%	+4.02%	-1.97%	+3.57%	+24.95%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALC Alcon	2.63	Moderate Buy	$84.76	20.79% Upside
BHC Bausch Health Cos	1.71	Reduce	$8.00	14.19% Upside
BLCO Bausch + Lomb	2.29	Hold	$18.75	11.68% Upside
BLCO Bausch + Lomb	2.29	Hold	$18.75	11.68% Upside

Current Analyst Ratings Breakdown

Latest BHC, BLCO, ALC, and BLCO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/3/2026	BLCO Bausch + Lomb	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$20.00 ➝ $21.00
8/3/2026	BLCO Bausch + Lomb	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$20.00 ➝ $21.00
7/31/2026	BHC Bausch Health Cos	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
7/30/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/30/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/28/2026	BLCO Bausch + Lomb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$21.00
7/24/2026	BLCO Bausch + Lomb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/24/2026	BLCO Bausch + Lomb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALC Alcon	$10.63B	3.26	$5.58 per share	12.57	$44.55 per share	1.58
BHC Bausch Health Cos	$10.85B	0.24	$7.37 per share	0.95	$1.02 per share	6.87
BLCO Bausch + Lomb	$5.32B	1.13	$1.66 per share	10.14	$18.40 per share	0.91
BLCO Bausch + Lomb	$5.32B	1.13	$1.66 per share	10.14	$18.40 per share	0.91

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALC Alcon	$980M	$1.66	42.27	18.04	1.87	7.70%	7.11%	4.98%	8/10/2026 (Estimated)
BHC Bausch Health Cos	$157M	-$2.96	N/A	1.94	N/A	-10.12%	-561.95%	6.31%	N/A
BLCO Bausch + Lomb	-$360M	-$0.48	N/A	15.84	0.52	-3.21%	4.14%	1.93%	N/A
BLCO Bausch + Lomb	-$360M	-$0.48	N/A	15.84	0.52	-3.21%	4.14%	1.93%	N/A

Latest BHC, BLCO, ALC, and BLCO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	ALC Alcon	$0.7480	N/A	N/A	N/A	$2.72 billion	N/A
7/29/2026	Q2 2026	BHC Bausch Health Cos	$0.96	$1.26	+$0.30	$0.68	$2.59 billion	$2.83 billion
5/5/2026	Q1 2026	ALC Alcon	$0.80	$0.85	+$0.05	$0.39	$2.64 billion	$2.71 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALC Alcon	N/A	N/A	N/A	N/A	4 Years
BHC Bausch Health Cos	N/A	N/A	N/A	N/A	N/A
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALC Alcon	0.19	2.20	1.39
BHC Bausch Health Cos	54.68	1.44	1.08
BLCO Bausch + Lomb	0.79	1.55	1.02
BLCO Bausch + Lomb	0.79	1.55	1.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALC Alcon	53.86%
BHC Bausch Health Cos	78.65%
BLCO Bausch + Lomb	11.07%
BLCO Bausch + Lomb	11.07%

Insider Ownership

Company	Insider Ownership
ALC Alcon	1.52%
BHC Bausch Health Cos	20.67%
BLCO Bausch + Lomb	1.45%
BLCO Bausch + Lomb	1.45%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALC Alcon	25,942	494.62 million	N/A	Optionable
BHC Bausch Health Cos	20,300	374.03 million	296.72 million	Optionable
BLCO Bausch + Lomb	13,000	357.06 million	351.88 million	Optionable
BLCO Bausch + Lomb	13,000	357.06 million	351.88 million	Optionable

BHC, BLCO, ALC, and BLCO Headlines

Recent News About These Companies

Bausch + Lomb (NYSE:BLCO) Price Target Raised to $21.00

August 3 at 8:11 AM | marketbeat.com

Bausch + Lomb Corporation (NYSE:BLCO) Receives Average Rating of "Hold" from Analysts

August 3 at 2:13 AM | marketbeat.com

Bausch + Lomb Earnings Call Signals Growing Momentum

July 31 at 8:30 PM | tipranks.com

Arrowstreet Capital Limited Partnership Sells 229,678 Shares of Bausch + Lomb Corporation $BLCO

July 31 at 3:12 AM | marketbeat.com

Bausch + Lomb (NYSE:BLCO) Research Coverage Started at UBS Group

July 31 at 2:42 AM | americanbankingnews.com

Bausch + Lomb Corporation (BLCO) Q2 2026 Earnings Call Transcript

July 30, 2026 | seekingalpha.com

Bausch & Lomb Announces Q2 2026 Financial Results for Quarter Ending June 30

July 29, 2026 | kalkinemedia.comK

Bausch + Lomb (NYSE:BLCO) exceeds Q2 CY2026 expectations

July 29, 2026 | msn.com

Bausch + Lomb Q2 Earnings Call Highlights

July 29, 2026 | marketbeat.com

Bausch + Lomb (NYSE:BLCO) Issues Earnings Results

July 29, 2026 | marketbeat.com

Bausch + Lomb (BLCO) Q2 Earnings Meet Estimates

July 29, 2026 | zacks.com

Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance

July 29, 2026 | aol.comA

Bausch + Lomb: Q2 Earnings Snapshot

July 29, 2026 | chron.com

Bausch & Lomb Corp (BLCO) Q2 2026 Earnings

July 29, 2026 | 247wallst.com

(BLCO) Bausch + Lomb anticipe un chiffre d'affaires compris entre 5,44 et 5,54 milliards de dollars pour l'exercice 2026, contre une estimation FactSet de 5,47 milliards de dollars

July 29, 2026 | zonebourse.comZ

Bausch + Lomb Corporation 2026 Q2 - Results - Earnings Call Presentation

July 29, 2026 | seekingalpha.com

Bausch + Lomb (NYSE:BLCO) Raised to Strong-Buy at UBS Group

July 29, 2026 | marketbeat.com

Bausch + Lomb (BLCO) to Announce Earnings on Wednesday

July 28, 2026 | americanbankingnews.com

Whitebox Advisors LLC Buys 150,641 Shares of Bausch + Lomb Corporation $BLCO

July 27, 2026 | marketbeat.com

Bausch + Lomb Corporation (BLCO) Receives a Buy from RBC Capital

July 22, 2026 | theglobeandmail.com

Bausch + Lomb (BLCO) Expected to Release Quarterly Earnings on Wednesday

July 22, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BHC, BLCO, ALC, and BLCO Company Descriptions

Alcon NYSE:ALC

$70.17 +1.23 (+1.78%)

Closing price 03:59 PM Eastern

Extended Trading

$70.20 +0.03 (+0.04%)

As of 04:45 PM Eastern

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Bausch Health Cos NYSE:BHC

$7.01 +0.12 (+1.68%)

Closing price 03:59 PM Eastern

Extended Trading

$6.90 -0.11 (-1.58%)

As of 04:44 PM Eastern

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch + Lomb NYSE:BLCO

$16.79 -0.12 (-0.72%)

Closing price 03:59 PM Eastern

Extended Trading

$16.75 -0.04 (-0.23%)

As of 04:46 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Bausch + Lomb NYSE:BLCO

$16.79 -0.12 (-0.72%)

Closing price 03:59 PM Eastern

Extended Trading

$16.75 -0.04 (-0.23%)

As of 04:46 PM Eastern

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BHC, BLCO, ALC, and BLCO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BHC, BLCO, ALC, and BLCO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BHC, BLCO, ALC, and BLCO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BHC, BLCO, ALC, and BLCO Company Descriptions

Alcon NYSE:ALC

Bausch Health Cos NYSE:BHC

Bausch + Lomb NYSE:BLCO

Bausch + Lomb NYSE:BLCO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BHC, BLCO, ALC, and BLCO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BHC, BLCO, ALC, and BLCO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BHC, BLCO, ALC, and BLCO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BHC, BLCO, ALC, and BLCO Company Descriptions

Alcon NYSE:ALC

Bausch Health Cos NYSE:BHC

Bausch + Lomb NYSE:BLCO

Bausch + Lomb NYSE:BLCO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools